Compound information
- Natural Products
- ZC603461
- Molecular Formula
- C16H22N2O6S
- Molecular Weight
- 370.119857424 g/mol
- Structure
-
- IUPAC Name
- ethyl 4-(4-ethoxycarbonylphenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C16H22N2O6S/c1-3-23-15(19)13-5-7-14(8-6-13)25(21,22)18-11-9-17(10-12-18)16(20)24-4-2/h5-8H,3-4,9-12H2,1-2H3
- InChI Key
- RCLOKFZMBCJARL-UHFFFAOYSA-N
- SMILES
- CCOC(=O)c1ccc(S(=O)(=O)N2CCN(C(=O)OCC)CC2)cc1
- Source
- ZINC000016092314
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 25 | Ring Count | 2 |
Heteroatom Count | 9 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 93.22 Å2 | LogP | 2.294 |
LogS | -3.49 | LogD | 2.612 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.039 | Pgp substrate | 0.032 |
HIA | 0.978 | F20 % | 0.034 |
F30 % | 0.313 | Caco-2 | -4.413 |
MDCK | -4.657 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.157 | PPB | 65.078 |
VD | 1.408 | Fu | 0.53 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.269 | CYP1A2 substrate | 0.546 |
CYP2A6 substrate | 0.671 | CYP2B6 substrate | 0.693 |
CYP2C19 inhibitor | 0.603 | CYP2C19 substrate | 0.784 |
CYP2C8 substrate | 0.567 | CYP2C9 inhibitor | 0.924 |
CYP2C9 substrate | 0.999 | CYP2D6 inhibitor | 0.104 |
CYP2D6 substrate | 0.355 | CYP2E1 substrate | 0.306 |
CYP3A4 inhibitor | 0.026 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.587 | CL | 5.341 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.505 | Hepatotoxicity | 0.214 |
Mutagenicity | 0.114 | Rat Oral Acute Toxicity | 0.024 |
FDAMDD | 0.021 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.052 | Eye Corrosion | 0.001 |
Eye Irritation | 0.013 | Respiratory Toxicity | 0.01 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.801 | IGC50 | 3.458 |
LC50FM | 2.855 | LC50DM | 0.722 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.33 | NR-AR-LBD | 0.36 |
NR-AhR | 0.044 | NR-Aromatase | 0.023 |
NR-ER | 0.363 | NR-ER-LBD | 0.443 |
NR-PPAR-gamma | 0.12 | SR-ARE | 0.254 |
SR-ATAD5 | 0.316 | SR-HSE | 0.066 |
SR-MMP | 0.013 | SR-p53 | 0.03 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.